Dallas, TX -- (SBWIRE) -- 10/10/2011 -- GBI Research, a leading business intelligence provider, has released its latest research, "OLED Displays and Lighting Market to 2020 - Technological Innovations Lead to Cost Efficient Products and New Aesthetics". The report gives an in-depth analysis of the global Organic Light Emitting Diodes (OLED) market for displays and lighting, covering four major regions – North America (USA and Canada), Europe, Asia–Pacific. The report covers market revenue forecasts for the OLED market (Displays and Lighting) from 2005-2020 It also provides market revenues breakdown for displays by application types; Cell Phones, Televisions, IT Monitors and Others and technology type; Passive Matrix Organic Light Emitting Diode (PMOLED) Displays and Active Matrix Organic Light Emitting Diode (AMOLED) Display.

For OLED lighting segment, the report provides covers market revenue forecasts from 2010-2020. It also provides market revenues breakdown for displays by application types; Specialty Lighting, Architecture Lighting, Back Lighting, Signage and General Illumination. The research analyzes market dynamics, challenges and trends, supply chain analysis, potential applications, opportunities, regulatory framework, major projects undertaken for technology developments in the three most significant regions, North America, Europe and Asia-Pacific.. This report is built using data and information sourced through primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope
• The Global OLED market revenue for Displays and Lighting with geographic analysis covering three regions – North America (USA and Canada), Europe, Asia – Pacific.
• The OLED market for Displays in four application types - Cell Phones, Televisions, IT Monitors and Others
• The OLED market for Displays by technology types - Passive Matrix Organic Light Emitting Diode (PMOLED) Displays and Active Matrix Organic Light Emitting Diode (AMOLED) Display.
• The OLED market for Lighting in four application types - Specialty Lighting, Architecture Lighting, Back Lighting, Signage and General Illumination
• Technology Overview of Displays and Lighting
• The Regulatory Framework, Developmental Activities, Major Technology Projects, Technology Roadmap, Supply Chain and Competitive Analysis
• Insights into the major trends, drivers and challenges in the overall industry.
• Market revenue from 2005 to 2010, with forecasts to 2020.
• Business overview, SWOT Analysis and review of the operational metrics of key companies in the OLED Lighting Industry. These include Osram, GE Lighting, Philips, and Lumiotec.

Reasons to buy
• Identify key markets and investment opportunities in the OLED displays and lighting market.
• Make decisions based on strong historical and forecast data and detailed growth opportunities analysis.
• Understand and respond to the market dynamics in North America (The US and Canada), Europe, Asia–Pacific regions.
• Position yourself to take maximum advantage of the market's growth potential.
• Identify the risks associated with the market and transform them into opportunities for future growth.
• Identify the scope of emerging technologies and applications in the market.

http://www.reportsnreports.com/reports/131023-oled-displays-and-lighting-market-to-2020-technological-innovat.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 10/10/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, "Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market", which provides insights into the global ophthalmology therapeutics market forecast until 2017. The report provides an in-depth analysis of the six therapeutic indications of ophthalmology, namely glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration. The report also examines the ophthalmology therapeutics treatment usage patterns for the covered indication. In addition, the report includes insights into the ophthalmology R&D pipeline. GBI Research analysis shows that the overall global ophthalmology market for glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration was valued at $10.3 billion in 2010. The market is expected to grow at a CAGR of 3.6% for the forecast period and will reach $13.2 billion by 2017. The global market revenues are expected to increase due to the introduction of new molecules which are currently in the regulatory filing stage and those in the later stages of development.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The report also examines global ophthalmology treatment usage patterns and includes insights into the ophthalmology therapeutics R&D product pipeline.

The top pharmaceutical companies in ophthalmology market are Pfizer Inc., Allergan Inc., Alcon Inc, Novartis AG., Merck & co. Inc and Roche. Approximately 70% of the market is covered by these above six companies.

Scope
• The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration therapeutics market.

• Data and analysis for the global ophthalmology therapeutics market

• Annualized market data for the ophthalmology therapeutics market from 2002 to 2010, with forecasts to 2017

• Key drivers and restraints that have had a significant impact on the market

• The competitive landscape of the global ophthalmology therapeutics market

• Key M&A activities and Licensing Agreements that took place in the ophthalmology therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -

• Align your product portfolio to the markets with high growth potential.

• Develop market entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.

• Device a more tailored country strategy through the understanding of key drivers and barriers of the ophthalmology market.

• Develop key strategic initiatives by understanding the key focus areas and leading companies.

• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

http://www.reportsnreports.com/reports/131025-ophthalmology-therapeutics-market-to-2017-protein-kinase-inhibi.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 10/06/2011 -- GBI Research, the leading business intelligence provider, has released its latest research "Metabolic Disorders Therapeutics Market to 2017 – Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value", which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report provides an in-depth analysis of the major metabolic diseases including Diabetes, Obesity and Dyslipidemia. The report also provides the share of generics in global metabolic diseases as well as in each indication market. It also provides the treatment algorithm flow for each three indications. The report examines the global metabolic diseases treatment usage patterns. In addition, the geographical distribution of metabolic diseases and market across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the metabolic diseases R&D product pipeline and explores the competitive landscape including major players in metabolic disorder therapeutics market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in metabolic disorder therapeutics market.

Scope
• The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the global metabolic disorder therapeutics market for the three indications that includes Diabetes, Obesity and Dyslipidemia.

• The report covers:

• Data and analysis on the metabolic disorder therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.

• Annualized market data for the metabolic disorder therapeutics market from 2002 to 2010, with forecasts to 2017 for three indications which includes diabetes, obesity and dyslipidemia

• Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.

• Share of the generics in global metabolic disorder therapeutics market and for the market of each indication that is covered in the report.

• Key drivers and restraints that have had a significant impact on the market.

• The competitive landscape of the global metabolic disorder market including top companies benchmarking. The key companies studied in this report are Pfizer Inc., Novo Nordisk, Sanofi, Takeda, Eli Lilly, GlaxoSmithKline and Merck & Co. Inc.

• Key M&A activities and Licensing Agreements that took place in 2009 and 2011 in the metabolic disorder therapeutics market.

Reasons to Buy
• The report will assist business development and marketing executives to strategize their product launches, by allowing them to:

• Align your product portfolio to the markets with high growth potential.

• Build effective strategies to launch their pipeline products by identifying potential geographies.

• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.

• Develop key strategic initiatives by studying the key strategies of top competitors.

• Device a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.

• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.

• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

http://www.reportsnreports.com/reports/130632-metabolic-disorders-therapeutics-market-to-2017-patent-expiry-o.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 10/06/2011 -- GBI Research's report 'Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers' provides an in-depth analysis of the current patient recruitment scenario for major indications under dermatology. The report analyzes a number of clinical trials conducted for major indications. It provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year. An analysis of the total number of patients recruited for major indications is given. The report analyzes total number of patients recruited by phase of clinical trial, geography and major sponsors. An analysis of the average number of patients recruited per trial per year for various indications is also given. Clinical trials are being conducted on dermatological diseases in order to find better treatment options. There has been an increase in the number of clinical trials conducted due to a rise in the prevalence of dermatology disorders. A clinical trial is one of the most critical parts of the drug development process.

Scope
• The report analyzes the clinical trial recruitment trends for pharmaceutical companies for various dermatological trials. Its scope includes:

• Insight on clinical trials conducted for major indications of dermatological diseases such as acne vulgaris, atopic dermatitis, candidiasis, herpes zoster and alopecia between 2000 and 2010.

• The status of patient recruitment by geography, sponsor company, year and stage of development.

• Analysis of the average number of patients recruited per trial for major indications per year.

• Analysis of the average number of patients recruited per trial for major indications by stage of development.

• The prevalence population in India, China and Brazil for all major indications from 2010 to 2017.

Reasons to Buy• The report will enhance your decision making capability. It will allow you to:

• Identify and understand the status of clinical trials conducted for major dermatology indications from 2000 to 2010.

• Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.

• Identify the prevalence population for major indications until 2017.

• Identify the average number of patients recruited by stage of development and across years for all major indications.

• Identify the indication for which the most trials are conducted and most patients are recruited.

http://www.reportsnreports.com/reports/130633-clinical-trial-recruitment-in-dermatology-most-trials-focus-on-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 10/06/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, "Contraceptives Market to 2017" which provides insights into global contraceptives market and market forecast until 2017. Report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts. The report provides an in-depth analysis of the contraceptives used. The report provides an in-depth analysis of the oral contraceptives, topical contraceptive, injectable contraceptive, intrauterine devices, condoms and vaginal rings. The report examines the oral, topical and injectable contraceptives treatment usage patterns. The report also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape including major players in contraceptives market.

Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in contraceptives market.

Scope
• The report analyzes market characterization, pipeline analysis and key M&A trends in the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.

• The scope of this report includes:

• Data and analysis on the contraceptives market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.

• Annualized market data for the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002 to 2010, with forecasts to 2017.

• Market data on the therapeutic landscape which covers oral, topical, injectable contraceptive and includes market revenues, treatment usage patterns and annual cost of therapy.

• Key drivers and restraints that have had a significant impact on the market

• The competitive landscape of the contraceptives market which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.

• Key M&A activities and Licensing Agreements that took place from 2005 to 2011 in the contraceptives market.

Reasons to Buy
• The report will enhance your decision making capability. It will allow you to

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.

• Device a more tailored country strategy through the understanding of key drivers and barriers of the contraceptives market.

• Develop key strategic initiatives by understanding the key focus areas of leading companies.

• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

http://www.reportsnreports.com/reports/130390-contraceptives-market-to-2017-hormonal-contraceptives-and-stron.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 10/06/2011 -- GlobalData, the industry analysis specialist, has released its new report, "Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Atopic Dermatitis Therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Atopic Dermatitis Therapeutics sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

http://www.reportsnreports.com/reports/130644-atopic-dermatitis-therapeutics-pipeline-assessment-and-market-f.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

Scope

The report provides information on the key drivers and challenges of the Atopic Dermatitis Therapeutics market. Its scope includes:

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

• Analysis of the current and future competition in the seven key countries Atopic Dermatitis Therapeutics market.

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Atopic Dermatitis Therapeutics market.

• Analysis of key recent licensing and partnership agreements in Atopic Dermatitis Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis Therapeutics market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Atopic Dermatitis Therapeutics market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

• What's the next big thing in the global Atopic Dermatitis Therapeutics market landscape? - Identify, understand and capitalize.

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 10/05/2011 -- GlobalData's new report 'Eagle Ford Shale in the US, 2011 - Oil Shale Market Analysis and Forecasts to 2020' analyzes the recent activities in the Eagle Ford shale play in the US.

The report details the drilling activity in the play by analyzing the permits issued in Eagle Ford shale by period, county and also by major operators. It also provides the well costs and acreage costs. The report gives the major players in the shale play in terms of acreage and production. It also details the expected production from the shale play by 2020. The report details the major recent M&A activities in the play and provides the future plans of major companies involved in the Eagle Ford shale play.

The Eagle Ford shale play is encountering increased activity and interest from oil and gas companies. Increased drilling activities, acreages and production in the shale play are apt indicators of this development. As of June 2011, the Texas Rail Road Commission (RRC) had issued a total of 1,241 drilling permits in the Eagle Ford shale play during the period January to June 2011. The figure for 2010 was 1,010. Additionally, substantial investments are to be seen in the shale play. About $4.6 billion investments in capital expenditure are expected in the near future from major companies.

Scope
The report analyzes the activities in the US Eagle Ford shale. The scope of the report includes -
• Major companies in the Eagle Ford shale by acreage and by production.
• Eagle Ford shale production trends and expected production during 2010-2020.
• Cost per well and acreage cost for major players in the shale play.
• Eagle Ford shale drilling details by period, county and operators.
• Major merger and acquisition in the Eagle Ford shale play during 2010-2011.
• Analysis of operations of major companies in the play such as EOG Resources, Petrohawk and others.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Understand the changing dynamics of the oil and gas industry in the US by understanding the role that shale plays in the energy industry of the country.
• Develop business strategies with the help of specific insights about this shale play.
• Understand trends and activities in Eagle Ford shale play.
• Understand the market positioning of the major players in this shale play.
• Increase future revenue and profitability with the help of insights about future opportunities and critical success factors in the shale plays.

http://www.reportsnreports.com/reports/130643-eagle-ford-shale-in-the-us-2011-oil-shale-market-analysis-and-.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 10/05/2011 -- This report includes a detailed analysis of the current investment climate in the country's power sector and over the next decade across 6 broad parameters. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the final country ranking in that region. The study also maps the relative ranking of the key countries in the region according to the current investment opportunities in the country and that by 2020.

This report also examines the country's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market's regulatory structure, supply and demand balance, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided.

Scope
• Analysis of the current investment climate in the country's power sector across six parameters and over the next decade
• Relative ranking of the key country's in the region according to the current investment opportunities in the country and that by 2020.
• Statistics for installed capacity, power generation and consumption from 2000 to 2010, forecast forward 19 years to 2030
• Break-up by technology, including thermal, hydro, renewable and nuclear
• Data on key current and upcoming projects
• Information on grid interconnectivity, distribution losses and power exports and imports
• Policy and regulatory framework governing the market
• Detailed analysis of top market participant, including market share analysis and SWOT analysis
• Data sourced from proprietary databases and primary interviews with key participants across the value chain

Reasons to buy
• Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country's power sector
• Identification of key factors driving investment opportunities in the country's power sector
• Facilitate decision-making based on strong historic and forecast data
• Develop strategies based on the latest regulatory events
• Position yourself to gain the maximum advantage of the industry's growth potential
• Identify key partners and business development avenues
• Identify key strengths and weaknesses of important market participants
• Respond to your competitors' business structure, strategy and prospects

http://www.reportsnreports.com/reports/130795-luxembourgpowermarketoutlookto2030-businesspropensityindicator(bpi)markettrendsregulationandcompetitivelandscape.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 10/04/2011 -- GlobalData, the industry analysis specialist, has released its new report, "Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global rheumatoid arthritis therapeutics market. The report identifies the key trends shaping and driving the global rheumatoid arthritis therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global rheumatoid arthritis therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
The report provides information on the key drivers and challenges of the rheumatoid arthritis therapeutics market. Its scope includes:

• Annualized revenue data from seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) in the rheumatoid arthritis therapeutics market from 2005 to 2010, and forecasts for eight years to 2018.

• Pipeline analysis data, providing analysis split across the different phases, mechanisms of action being developed and emerging trends in the pipeline. Pipeline candidates fall under a variety of major therapeutic classes such as p38 kinase inhibitors, Janus Kinase Inhibitors (JAK), tyrosine kinase inhibitors, dihydrofolate reductase inhibitors, cyclooxygenase (COX) inhibitors, Dihydroorotate dehydrogenase (DHODH) inhibitors, interleukin inhibitors, tumor necrosis factor (TNF) inhibitors, chemotaxis inhibitors, Vascular Adhesion Protein-1 (VAP 1) inhibitors, granulocyte macrophage colony stimulating factor (GM-CSF) inhibitors, Toll-like receptors (TLRs) and anti-CD 20 monoclonal antibodies.

• Analysis of the current and future competition in the global rheumatoid arthritis therapeutics market. The key market players covered are AstraZeneca PLC, Eli Lilly and Company Eisai Co., Ltd GlaxoSmithKline plc, Pfizer Inc, Sanofi, Merck & Co., Inc., Novartis AG and Regeneron Pharmaceuticals, Inc.

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the rheumatoid arthritis therapeutics market.

• Analysis of key recent licensing and partnership agreements in the rheumatoid arthritis therapeutics market.

Reasons to buy
The report will enhance your decision-making capability. It will allow you to:
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.

• Develop business strategies by understanding the trends shaping and driving the global rheumatoid arthritis therapeutics market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global rheumatoid arthritis therapeutics market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.

• What's the next big thing in the global rheumatoid arthritis therapeutics market landscape? – Identify, understand and capitalize.

http://www.reportsnreports.com/reports/130635-rheumatoid-arthritis-therapeutics-pipeline-assessment-and-marke.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/30/2011 -- GlobalData, the industry analysis specialist, has released its new report, "Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Neuropathic Pain Therapeutics market. The report identifies the key trends shaping and driving the global Neuropathic Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Neuropathic Pain Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
The report provides information on the key drivers and challenges of the Neuropathic Pain Therapeutics market. Its scope includes -

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Neuropathic Pain Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

• Analysis of the current and future competition in the seven key countries Neuropathic Pain Therapeutics market.

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Neuropathic Pain Therapeutics market.

• Analysis of key recent licensing and partnership agreements in Neuropathic Pain Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the global Neuropathic Pain Therapeutics market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Neuropathic Pain Therapeutics market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

• What's the next big thing in the global Neuropathic Pain Therapeutics market landscape? - Identify, understand and capitalize.

http://www.reportsnreports.com/reports/129400-neuropathic-pain-therapeutics-pipeline-assessment-and-market-fo.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 09/30/2011 -- GlobalData, the industry analysis specialist, has released its new report, "Cytomegalovirus (CMV) Infections- Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Cytomegalovirus (CMV) Infections market. The report identifies the key trends shaping and driving the global Cytomegalovirus (CMV) Infections market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Cytomegalovirus (CMV) Infections sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
The report provides information on the key drivers and challenges of the Cytomegalovirus (CMV) Infections market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Cytomegalovirus (CMV) Infections market revenues data from 2005 to 2009, forecast for eight years to 2018.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Cytomegalovirus (CMV) Infections market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Cytomegalovirus (CMV) Infections market.

- Analysis of key recent licensing and partnership agreements in Cytomegalovirus (CMV) Infections market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Cytomegalovirus (CMV) Infections market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Cytomegalovirus (CMV) Infections
market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- Whats the next big thing in the global Cytomegalovirus (CMV) Infections market landscape? – Identify, understand and capitalize.

http://www.reportsnreports.com/reports/129401-cytomegalovirus-cmv-infections-pipeline-assessment-and-market.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 09/30/2011 -- GlobalData, the industry analysis specialist, has released its new report, "Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global ALL market. The report identifies the key trends shaping and driving the global ALL market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global ALL sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimates the major markets (the US, the UK, Italy, Spain, France, Germany and Japan) for acute lymphocytic leukemia (ALL) therapeutics was valued at $427.6m in 2010 and forecasts it to grow at a Compound Annual Growth Rate (CAGR) of 2.9% to reach $524.0m by 2017. This growth is primarily attributed to the expected launch of Phase III pipeline candidates Marqibo (vincristine sulfate liposomes injection), GRASPA (asparaginase loaded into erythrocytes), recombinant asparaginase (asparaginase) and Depocyt (liposomal cytarabine) during the forecast period. The moderate growth rate is primarily attributed to the patent expiry of Gleevec in 2015 in the US; 2016 in Europe, Clolar in 2015 in Europe and Arranon in 2017 in US; 2013 in Europe.

Scope
The report provides information on the key drivers and challenges of the acute lymphocytic leukemia market. Its scope includes:

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) ALL therapeutics market revenues data from 2005 to 2010, forecast for seven years to 2017.

• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes such as tyrosine kinase inhibitor, DNA polymerase inhibitor, histone deacetylase (HDAC) inhibitor, dihydrofolate reductase inhibitor and Eg5 Inhibitor.

• Analysis of the current and future competition in the seven key countries ALL therapeutics market. Key market players covered are Talon Therapeutics, Inc., Pfizer Inc, Genzyme Corporation, Erytech Pharma and Micromet, Inc.

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the ALL therapeutics market.

• Analysis of key recent licensing and partnership agreements in ALL therapeutics market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the global ALL therapeutics market.

• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global acute lymphocytic leukemia market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

• What's the next big thing in the global ALL therapeutics market landscape? - Identify, understand and capitalize.

http://www.reportsnreports.com/reports/129399-acute-lymphocytic-leukemia-all-therapeutics-pipeline-assessme.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Oman Gas Markets, 2011” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/30/2011 -- This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Oman. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in Oman. The report compares the investment environment in Oman with other countries in the region. The profiles of the major companies operating in the natural gas sector in Oman together with the latest news and deals are also included in the report.

Scope
• Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.

• Historical and forecast data and information for all the major gas fields, (Liquified Natural Gas) LNG Terminals and pipelines in Oman for the period 2000-2015.

• Operator and equity details for major natural gas assets in Oman.

• Key information relating to market regulations, key energy assets and the key companies operating in the Oman's energy industry.

• Information on the top companies in the Oman including business description, strategic analysis, and financial information.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

• Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy
• Gain a strong understanding of the country's energy market.

• Facilitate market analysis and forecasting of future industry trends.

• Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.

• Assess your competitor's major natural gas assets and their performance.

• Analyze the latest news and financial deals in the gas sector of each country.

• Develop strategies based on the latest operational, financial, and regulatory events.

• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.

• Identify and analyze the strengths and weaknesses of the leading companies in the country.

http://www.reportsnreports.com/reports/129397-oman-gas-markets-2011.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 09/29/2011 -- GBI Research's new report, "Visible Light Communication (VLC) - A Potential Solution to the Global Wireless Spectrum Shortage", provides the key information and analysis on Visible Light Communication technology and market. Visible Light Communication or VLC is a method by which Light Emitting Diodes (LEDs) are used to transmit data using visible light as a transmitting medium. With the increasing usage of data over mobile phones and other wireless devices, spectrum shortage appears to be a real problem for which VLC can be offered as a potential solution. This solution is explained in detail in the report.

VLC technology can be used in a number of applications or end user segments like wireless networking, intelligent traffic management systems, home networking system, powerline communication and underwater communication.

VLC technology based devices primarily use LEDs, Opto-couplers and Image Sensors as components and each one represents a unique industry that has tremendous growth potential due to the rise of a new technology. Visible Light Communication based products are primarily dependent on efficient and low cost LEDs for fast data transmission rates and this is an important factor in the faster launch of commercial VLC based devices. The report explains each component type accompanied with revenues and forecasts till 2015.

GBI Research estimates that globally, around $100 million is invested in the research of Visible Light Communication technology and even major companies are conducting trials on VLC for incorporating in future products. This report explains in detail about the various key players in both the pure research centers of institutes and the commercial companies globally.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

• In-depth explanation of the solution from Visible Light Communication for the potential problem of wireless spectrum shortage.

• Key VLC market segments such as PowerLine Communication, Underwater Communication, Visible Light ID system, Optical Communication, Ubiquitous Networking and Intelligent Traffic Management Systems have been covered.

• Market Size for different component types used in VLC based devices in terms of sales revenue. Forecast forward until 2015

• A Comparative Case Study between Visible Light Communication and Infrared Communication.

• VLC initiatives of various VLC technology research centers and key market players are explained in detail.

• Comprehensive profiles of key players such as LVX Systems, Intel Corporation, Nakagawa Laboratories, Intel Corporation, OMEGA, Visible Light Communication Consortium and so on have been provided.

Reasons to buy

• Exploit growth opportunities across various IC component types specific to Visible Light Communication industry.

• Information about the most recent product and technology developments in the Visible Light Communication market.

• What is the future demand potential of different end user applications in Visible Light Communication market– Identify, understand and capitalize.

• Develop business strategies by understanding the trends, research and developments that are driving the Visible Light Communication market across the globe.

• Understand the competitors operating in the VLC market from the company and institutes profiles.

• Have an in-depth and holistic understanding of Visible Light Communication in technical and commercial perspectives.

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 09/28/2011 -- GBI Research, the leading business intelligence provider, has released its latest research "Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth". The report provides in-depth analysis of drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2017 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope
The scope of this report includes -
• Annualized market data for the blood disorders market from 2002 to 2010, forecast forward to 2017.
• Analysis of the leading therapeutic segments, including anemia, thrombosis, neutropenia, hemophilia A, hemophilia B, hemophilia C, von Willebrand's disease and Alexander disease.
• Analysis of the blood disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
• Market characterization of the blood disorders market, including market size, annual cost of treatment and treatment usage pattern.
• Key drivers and barriers that have a significant impact on the market.
• Coverage of pipeline molecules in various phases of drug development.
• Competitive benchmarking of leading companies. The key companies studied in this report are Amgen, Bristol-Myers Squibb, Sanofi-Aventis, Baxter and Centocor Ortho Biotech Inc.
• Key M&A activities, licensing agreements, that have taken place from 2004 to 2011 in the global blood disorders market.

Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

http://www.reportsnreports.com/reports/125776-blood-disorders-therapeutics-market-to-2017-patent-expiries-of-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dallas, TX -- (SBWIRE) -- 09/28/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, "Critical Healthcare Market to 2017 - Shift of Focus towards PCC, Factor Concentrates and Antithrombins due to Better Safety and Efficacy Profiles". The report provides in-depth analysis of drivers and barriers that impact the global critical health market. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts. The report analyzes the markets for factor XIII concentrates, fibrinogen concentrates, albumins, antithrombins and prothrombin complex concentrates in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. This includes treatment usage patterns, average annual cost of therapy and market size forecast until 2017 for the key geographies as well as the leading therapeutic segments. The report also provides information on the R&D product pipeline and explores the competitive landscape, including major players in the critical healthcare market. Finally, the report includes analysis on mergers and acquisitions (M&As) in the critical healthcare market.

http://www.reportsnreports.com/reports/125777-critical-healthcare-market-to-2017-shift-of-focus-towards-pcc-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

GBI Research indicates that the global critical healthcare market is still an untapped market, with small numbers of players contributing to a major proportion of the overall critical health market. The market grew at very sluggish growth rate in the historic period, possible due to the unavailability of many of the products in certain markets, especially in the US. GBI Research estimates that the overall critical healthcare market in 2010 was worth $1,130.7m, representing a Compound Annual Growth Rate (CAGR) of 5% between 2002 and 2010. The global critical healthcare market is expected to grow at a moderate rate of 2.8% between 2010 and 2017, and is expected to reach $1,372.4m in 2017. The increased availability and usage of PCC, albumin products and factor concentrates for the management of various bleeding complications, and high risk surgical settings such as trauma, PPH, cardiac surgery and liver diseases, will drive the market in future. Approvals and launches of new products such as Riastap, Corifact and Atryn, and the anticipated launch of recombinant products, will boost growth of the critical healthcare market in the forecast period.

Scope
The report covers -

• Data and analysis on the critical healthcare market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.

• Annualized market data for the critical healthcare market that includes markets for factor XIII concentrate, fibrinogen concentrate, antithrombin, prothrombin complex concentrate and albumin from 2002 to 2010, with forecasts to 2017.


• Market data on the geographical landscape and therapeutic landscape, including market size, market share, cost of therapy, sales volume and treatment usage patterns such as disease population, diagnosis population and prescription population.

• Key drivers and restraints that have had a significant impact on the market.

• The competitive landscape of the global critical healthcare market, including top companies benchmarking. The key companies studied in this report are CSL, Octapharma, Baxter, Grifols and LFB.

• Key M&A activities that took place in 2010 and 2011 in the critical healthcare market.

Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to -

• Align your product portfolio to the markets with high growth potential.

• Build effective strategies to launch their pipeline products by identifying potential geographies.

• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.

• Develop key strategic initiatives by studying the key strategies of top competitors.

• Devise a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.

• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.

• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

About Us
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/27/2011 -- GBI Research's new report, "Emerging Pharmaceutical Market in China - Forecast to Become The World's Third-Largest Pharmaceutical Market By 2013", provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategies that shape the industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Chinese pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope
The scope of this report includes -
• Overall pharma, biotech and outsourcing market structure.
• Market characterization, including market size
• CMO & CRO market size and growth
• Key drivers and barriers that have a significant impact on the market.
• Competitive benchmarking of leading companies.
• Key M&A activities and strategic partnership deals that have taken place in 2009

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.
• Device a more tailored country strategy through the understanding of key drivers and barriers of the country's pharmaceutical market.
• Develop key strategic initiatives by understanding the key focus areas of leading companies.
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

http://www.reportsnreports.com/reports/125775-emerging-pharmaceutical-market-in-china-forecast-to-become-the-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/27/2011 -- GBI Research has released its latest research "Innovative R&D Strategies and Models - Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs", which provides insights into effective innovative strategies adopted by the pharmaceutical and biotechnology industry. The report examines numerous case studies of various R&D strategies such as outsourcing, offshoring, internal reorganization, R&D restructuring, risk sharing, public-private partnerships and others.

In-depth analysis of the report is based on propriety databases, primary and secondary research and in-house analysis by GBI Research's team of experts.

Scope
The scope of this report includes -
• Strategies adopted by pharmaceutical and biotechnology industry participants to succeed in the highly competitive pharmaceutical market
• Analysis of challenges faced by industry participants in increasing R&D output
• Analysis of strategies that have been ineffective in the pharmaceutical industry and those that have failed to achieve objectives
• Analysis on the role of CROs in improving R&D efficiencies in the pharmaceutical industry
• Key M&A activities and licensing agreements that have been aimed at increasing R&D outcomes

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Understand the different types of strategies being adopted in the industry to increase R&D outcomes
• Build effective strategies to improve R&D efficiencies through comprehension of strategies that worked and those that didn't work
• Analyze numerous case studies on various strategies adopted by the pharmaceutical industry to evaluate the best strategies
• Compare strategies adopted in-house to those adopted in-house to evaluate and forecast outcomes

http://www.reportsnreports.com/reports/125774-innovative-rd-strategies-and-models-outsourcing-strategic-par.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/27/2011 -- GBI Research has released its latest report, "Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance" that provides key data, information and analysis of the major trends and developments in post marketing clinical research. The report provides a comprehensive insight into key technological developments, new approaches towards risk mitigation. The report talks about the key regulations, drug classes that require REMS and case studies of drugs for which REMS is required. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research's team of industry experts.

Scope
The scope of the report includes -
• Key technological developments, new approaches and strategies to mitigiate drug safety risks
• Preclinical outsourcing market forecast, 2010-2017.
• Analysis of regulation in each of the top geographies in US, Europe and Japan
• Key drivers and barriers that have a significant impact on the industry

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Evaluate the effectiveness of REMS against various classes of drugs that have a poor safety record
• Understand best practices through case studies of REMS application in the industry
• Develop effective strategies to maximize the advantages through the understanding of REMS

http://www.reportsnreports.com/reports/125773-post-marketing-clinical-research-rems-the-latest-reformation-d.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/27/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, "Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline", provides in-depth analysis of unmet needs, drivers and barriers that impact the global coagulation disorders market. The report analyzes the markets for coagulation disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Market size, annual cost of therapy and treatment usage patterns are forecast until 2016 for the key geographies, as well as the leading therapeutic segments which includes hemophilia A, hemophilia B and von Willebrand Disease. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global coagulation disorders market.

Scope
The scope of this report includes:

• Annualized market data for the coagulation disorders market from 2002 to 2010, forecast forward to 2017.

• Analysis of the leading therapeutic segments, including hemophilia A, hemophilia B, and von Willebrand's disease (vWD).

• Analysis of the coagulation disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.

• Market characterization of the coagulation disorders market, including market size, annual cost of therapy and treatment usage patterns.

• Key drivers and barriers that have a significant impact on the market.

• Coverage of pipeline molecules in various phases of drug development.

• Competitive benchmarking of leading companies. The key companies studied in this report are Baxter International Inc, Bayer AG, Novo Nordisk A/S, Pfizer Inc and CSL Behring LLC.

• Key M&A activities and licensing agreements that have taken place between 2004 and 2010 in the global coagulation disorders market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to:

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.

• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with higher efficiency and better safety.

• Develop strategic initiatives by understanding the key focus areas of leading companies.

• Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

http://www.reportsnreports.com/reports/125772-coagulation-disorders-market-to-2017-hemophilia-a-the-largest-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GBI Research’s “Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/23/2011 -- GBI Research's report, "Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth" provides in-depth analysis of the, drivers and barriers that affect the global immunoglobulins market. The report analyzes the markets for immunoglobulins products in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Epidemiology, revenue, and annual cost of therapy are forecast until 2017 for the key geographies as well as seven key therapeutic segments. The report also provides profiles for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

http://www.reportsnreports.com/reports/125771-immunoglobulins-market-to-2017-off-label-usage-and-treatment-of.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

Scope
The scope of this report includes -

• Annualized market data for the immunoglobulins market from 2002 to 2010, and forecast to 2017.

• Analysis of the seven key therapeutic segments. These include PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura.

• Analysis of the immunoglobulins markets in the leading geographies of the world, which include the US, the top five countries in Europe and Japan.

• Market characterization of the immunoglobulins (PID, CIDP, multifocal motor neuropathy, myasthenia gravis, chronic lymphocytic leukemia, guillain-barre syndrome and idiopathic thrombocytopenic purpura) market, including market size, revenue analysis by the top seven geographies, annual cost of therapy, and epidemiology.

• Key drivers and barriers that have a significant impact on the market.

• Coverage of the pipeline molecules in various phases of drug development.

• Competitive profiling of the leading companies. The key companies studied in this report are Baxter International Inc., Biotest, Bio Products Laboratory Ltd., CSL Behring LLC, Kedrion, LFB, Octapharma, Talecris, and Grifols.

• Key M&A activities and licensing agreements between 2004 and 2011 in the global immunoglobulins market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -

• Align your product portfolio to the markets with high growth potential.

• Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.

• Develop key strategic initiatives by understanding the key focus areas of the leading companies.

• Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “PT PLN (Persero) - Power Plants and SWOT Analysis, 2011 Update” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/16/2011 -- The report contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company's business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company's operations and business divisions
• Corporate strategy - GlobalData's summarization of the company's business strategy.
• SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives' employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
• Understand and respond to competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

http://www.reportsnreports.com/reports/120079-pt-pln-persero-power-plants-and-swot-analysis-2011-update.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Glow Energy Public Company Limited - Power Plants and SWOT Analysis, 2011 Update” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/16/2011 -- The report contains the profile of the company that is involved in the field of power generation from thermal sources (coal, oil and gas). It contains a detailed description of the company's business operations (power plants, installed capacity, and generation), history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), key competitors, and major products and services.

Scope
• Major Power Plants (assets) - summarized and detailed information about the power plants (assets)
• Operational Metrics (capacity, generation, revenue, sales, number of consumers)
• Business description - A detailed description of the company's operations and business divisions
• Corporate strategy - GlobalData's summarization of the company's business strategy.
• SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands
• Key competitors - A list of key competitors.
• Key employees - A list of the key executives
• Executive biographies - A brief summary of the executives' employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
• Note*: Some sections may be missing if data is unavailable for the company.

Reasons to buy
• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
• Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
• Understand and respond to competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

http://www.reportsnreports.com/reports/111578-glow-energy-public-company-limited-power-plants-and-swot-analys.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Biogas Power in the United Kingdom (UK), Market Outlook to 2020, 2011 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/16/2011 -- Biogas Power in the United Kingdom (UK), Market Outlook to 2020, 2011 Update - Capacity, Generation, Power Plants, Regulations and Company Profiles" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information on the biogas power market. The report provides in depth analysis on global renewable power market and global biogas power market with forecasts up to 2020. The report analyzes the power market outlook in the UK (includes thermal conventional, hydro and other renewables) and provides forecasts up to 2020. The research details renewable power market outlook in the UK (includes wind, biopower and solar PV) and provides forecasts up to 2020. The report highlights installed capacity and power generation trends from 2001 to 2020 in the UK biogas power market. The research also showcases top active and upcoming plants in the country.

A detailed coverage on renewable energy policy framework governing the market along with policies specific to biogas power development in the UK are provided in the report. The research analyzes investment trends in the biopower power market in the UK and some of the major deals pertaining to the market are dealt in detail. The report also provides elaborate company profiles of some of the major market participants.

Scope
The scope of the report includes -
• Brief introduction and overview on global carbon emissions and global energy consumption.
• Historical data provided from 2001 to 2010 and forecasts until 2020.
• Overview on the overall renewable power market in the world, highlighting the fuel types – wind, solar PV, solar thermal, biogas and biomass.
• Detailed overview on the global biogas power market with capacity and generation forecasts to 2020.
• Power market scenario in the UK with capacity and generation forecasts to 2020, highlighting fuel types such as thermal conventional, hydro and other renewables.
• Renewable power market scenario in the UK with capacity and generation forecasts to 2020, highlighting fuel types such as wind, biomass and solar PV.
• The UK biogas power installed capacity and generation trends to 2020
• Major active and upcoming plants in the country.
• Deal volume and value analysis of the UK biopower market. Deals analyzed on the basis of M&A, Partnership, Asset Financing, Debt Offering, Equity Offering and PE/VC.
• Elaborate profiling of some of the major market participants.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to -
• Identify key growth and investment opportunities in the UK biogas power market.
• Position yourself to gain the maximum advantage of the market's growth potential by developing strategies based on the latest operational and regulatory events.
• Understand and respond to your competitors' business structure, strategy and prospects.
•Do deals with an understanding of the mergers and partnerships that have shaped the market.

The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

http://www.reportsnreports.com/reports/125160-biogas-power-in-the-united-kingdom-uk-market-outlook-to-2020-.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

GlobalData’s “Smart Grid Readiness in Power Utilities - Technology Installation Trends and Outlook to 2016” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/16/2011 -- GlobalData's latest research, "Smart Grid Readiness in Power Utilities - Technology Installation Trends and Outlook to 2016" provides an insight into the status of deployment of various smart grid technologies by utilities across the globe. Smart grids are efficient power delivery systems that utilize digital communication and advanced power electronics to integrate renewable energy resources and reduce transmission and distribution loss. The global deployment of smart grid technologies is expected to grow at a significant rate during the next few years until 2016. The deployments during the period 2005-2010 were restricted to North America and parts of Europe. This leaves a wide scope for the growth of smart grid technology deployment in Asia-Pacific, where utilities are struggling to reduce the inefficiencies in the power grid. The report provides information related to the past deployment trend and outlook for four different categories of smart grid technologies; integrated communication technologies, sensing and measurement technologies, cabling technologies and consumer interface technologies. The report covers the smart grid technology deployment activities in key nations across the globe.

Scope
• Key geographies including US, Canada, Germany, France, Spain, Italy, China, Australia, South Korea, Japan, Brazil and Mexico
• Deployment trend and outlook for integrated communication technologies in key countries
• Deployment trend and outlook for sensing and measurement technologies in key countries
• Deployment trend and outlook for cabling technologies in key countries
• Deployment trend and outlook for consumer interface technologies in key countries

Reasons to buy
• Facilitate decision-making based on technology deployment trends by utilities.
• Develop strategies for market penetration and product development
• Position yourself to gain the maximum advantage of the smart grid technology market's growth potential
• Identify key partners and business development avenues

http://www.reportsnreports.com/reports/120090-smart-grid-readiness-in-power-utilities-technology-installation.html

Browse All: http://www.reportsnreports.com/market-research/energy-and-power-supplies/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm